接受体外膜肺氧合治疗的患者发生真菌血症的结局
Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation.
作者信息
Rosas Melissa M, Sobieszczyk Michal J, Warren Whittney, Mason Phillip, Walter Robert J, Marcus Joseph E
机构信息
Pulmonary and Critical Care Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
Critical Care Division, Emergency Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
出版信息
Open Forum Infect Dis. 2022 Jul 25;9(8):ofac374. doi: 10.1093/ofid/ofac374. eCollection 2022 Aug.
Abstract
There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.
摘要
关于体外膜肺氧合（ECMO）并发真菌感染的治疗数据有限。在14例在ECMO期间发生真菌血流感染的患者中，8例（57%）存活至出院。在5例在拔管前完成治疗的患者中，2例（40%）出现复发性真菌感染。
相似文献
1
Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗的患者发生真菌血症的结局
Open Forum Infect Dis. 2022 Jul 25;9(8):ofac374. doi: 10.1093/ofid/ofac374. eCollection 2022 Aug.
2
Association Between Body Mass Index and Outcomes in Venoarterial Extracorporeal Membrane Oxygenation.体重指数与静脉-动脉体外膜肺氧合治疗结局之间的关联
Anesth Analg. 2022 Feb 1;134(2):341-347. doi: 10.1213/ANE.0000000000005689.
3
Survival of candida sepsis in extracorporeal membrane oxygenation.体外膜肺氧合治疗念珠菌败血症的生存率
Pediatr Crit Care Med. 2005 Nov;6(6):709-11. doi: 10.1097/01.pcc.0000165563.61181.fb.
4
Characterization of Extracorporeal Membrane Oxygenation Support for Single Ventricle Patients.单心室患者体外膜肺氧合支持的特征分析
World J Pediatr Congenit Heart Surg. 2020 Mar;11(2):183-191. doi: 10.1177/2150135119894294.
5
Incidence of healthcare-associated infections in patients with fever during the first 48 hours after decannulation from veno-venous extracorporeal membrane oxygenation.在脱机后 48 小时内发热的患者中，与血管-静脉体外膜肺氧合相关的院内感染发生率。
Perfusion. 2021 May;36(4):421-428. doi: 10.1177/0267659120948427. Epub 2020 Aug 21.
6
Delaying Decannulation After Extracorporeal Membrane Oxygenation Is Safe and Advantageous.体外膜肺氧合后延迟拔管是安全且有益的。
World J Pediatr Congenit Heart Surg. 2019 Jan;10(1):98-100. doi: 10.1177/2150135118805061.
7
Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study.体外膜肺氧合期间行肾脏替代治疗患者的结局：一项单中心回顾性研究。
Blood Purif. 2020;49(3):341-347. doi: 10.1159/000504287. Epub 2019 Dec 19.
8
Fungal infections in adult patients on extracorporeal life support.成人体外生命支持患者的真菌感染。
Crit Care. 2018 Apr 17;22(1):98. doi: 10.1186/s13054-018-2023-z.
9
Outcomes of Venoarterial Extracorporeal Membrane Oxygenation Patients Requiring Multiple Episodes of Support.需要多次支持的脉管体外膜氧合患者的结果。
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2357-2361. doi: 10.1053/j.jvca.2019.12.007. Epub 2019 Dec 11.
10
A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support.接受静脉-动脉体外膜肺氧合支持的大面积肺栓塞幸存者与非幸存者的回顾性比较。
Resuscitation. 2018 Jan;122:1-5. doi: 10.1016/j.resuscitation.2017.11.034. Epub 2017 Nov 8.
引用本文的文献
1
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.体外膜肺氧合患者的抗真菌药物剂量。
Clin Pharmacokinet. 2023 Jul;62(7):931-942. doi: 10.1007/s40262-023-01264-0. Epub 2023 Jun 10.
本文引用的文献
1
Impact of Invasive Fungal Diseases on Survival under Veno-Venous Extracorporeal Membrane Oxygenation for ARDS.侵袭性真菌病对急性呼吸窘迫综合征患者在静脉-静脉体外膜肺氧合支持下生存的影响。
J Clin Med. 2022 Mar 31;11(7):1940. doi: 10.3390/jcm11071940.
2
Pathogens attributed to central-line-associated bloodstream infections in US acute-care hospitals during the first year of the coronavirus disease 2019 (COVID-19) pandemic.2019 年冠状病毒病（COVID-19）大流行第一年美国急性护理医院与中心静脉导管相关的血流感染的病原体。
Infect Control Hosp Epidemiol. 2023 Apr;44(4):651-654. doi: 10.1017/ice.2022.16. Epub 2022 Feb 8.
3
Attributable Mortality of Candida Bloodstream Infections in the Modern Era: A Propensity Score Analysis.现代时代念珠菌血流感染的归因死亡率：倾向评分分析。
Clin Infect Dis. 2022 Sep 29;75(6):1031-1036. doi: 10.1093/cid/ciac004.
4
Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation.长期静脉-静脉体外膜肺氧合患者中念珠菌血症的发生率。
J Hosp Infect. 2022 Jan;119:49-53. doi: 10.1016/j.jhin.2021.09.014. Epub 2021 Sep 22.
5
Antifungal Prophylaxis for Adult Recipients of Veno-Venous Extracorporeal Membrane Oxygenation: A Cautionary Stance During the COVID-19 Pandemic.静脉-静脉体外膜肺氧合成年受者的抗真菌预防：COVID-19大流行期间的谨慎立场
ASAIO J. 2021 Jun 1;67(6):611-613. doi: 10.1097/MAT.0000000000001456.
6
Fungal infections in adult patients on extracorporeal life support.成人体外生命支持患者的真菌感染。
Crit Care. 2018 Apr 17;22(1):98. doi: 10.1186/s13054-018-2023-z.
7
Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impact on Patients' Outcome.体外膜肺氧合期间的医院感染：发病率、病因及对患者预后的影响
Crit Care Med. 2017 Oct;45(10):1726-1733. doi: 10.1097/CCM.0000000000002652.
8
Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention.体外膜肺氧合期间的感染：流行病学、风险因素、发病机制和预防。
Int J Antimicrob Agents. 2017 Jul;50(1):9-16. doi: 10.1016/j.ijantimicag.2017.02.025. Epub 2017 May 18.
9
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
10
Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome.成人接受体外膜肺氧合后获得的感染：危险因素和结局。
Infect Control Hosp Epidemiol. 2013 Jan;34(1):24-30. doi: 10.1086/668439. Epub 2012 Nov 21.
Zotero 插件